Sandy Srinivas
Publication Details
-
High-dose chemotherapy in poor-risk germ-cell tumors.
Oncology (Williston Park). 2000; (10): 1419-23; discussion 1427-30, 1433-4
Testicular cancer is a highly curable cancer. However, 30% of patients are refractory to standard therapy and will need additional therapy. This article focuses on the use of high-dose chemotherapy in germ-cell tumors. High-dose chemotherapy use is discussed both in the refractory setting and as either first-salvage or first-line therapy. Various criteria for risk assessment are also discussed.
Help
Trial Administration